Did you know? Hospitals vent toxic & environmentally-destructive anesthetic gas into the community air we all breathe on a daily basis.

Board of Directors

The Blue-Zone Team

Blue-Zone has assembled a team of seasoned executives and world-renowned scientists to sit on its Board of Directors.

Ms. Dusanka Filipovic, P. Eng.

Ms. Dusanka Filipovic, P. Eng., is the co-inventor of the Deltasorb® Technology and Vice Chair and President of the company. She subsequently acquired global commercialization rights for the Deltasorb® Technology from Praxair and launched Blue-Zone Technologies Ltd. Prior to that, while at Union Carbide Canada, she directed the overall development of the Delta™ Project. Ms. Filipovic has experience in the start-up and commercialization of technology-based companies, having served as co-founder & Deputy Chair Halozone Technologies Ltd., a publicly traded company, and E.E.R. Canada, an environmental engineering firm which was acquired by General Electric.

Mr. Vaughn Goettler, MBA

Mr. Vaughn Goettler, MBA, is the Chief Executive Officer of the company. He has extensive experience in start-ups, turnarounds, operations, as well as acquisitions & divestitures of service companies in industrial/medical gases, waste and energy, heating & air conditioning fields. He was the: Founder & CEO of AirTime Canada ULC; CEO of Union Energy Inc.; Vice President of Canadian Waste Systems Inc.; Director, Canadian Operations with Laidlaw Waste Systems Limited; and President of Welders Service Inc., (a Union Carbide/Praxair Company).

Mr. Hank Klakurka

Mr. Hank Klakurka is the former CEO of Merck Generics Group. He draws from 33 years experience in both branded & generic Pharma as CEO for Merck Generics Group in Germany; Regional Director Americas for Merck Generics Group; President of Novex Pharma (division of Apotex Inc.); VP Operations for Astra Pharma Inc. and VP Manufacturing for Schering-Plough among others. Mr. Klakurka is currently advising Private Equity firms on Pharma Sector acquisitions as well as advising several Pharma companies on matters of strategy, business development and patents.

Mr. Martin Marino

Martin Marino has nearly 30 years corporate experience in the functions of law, corporate and business development. Mr. Marino spent 10 years in Pharma in the roles of Chief Legal Counsel for Merck Generics Group, VP & General Counsel for Genpharm Inc and VP International Corporate Development for Apotex Inc. He is currently serving as Director to Microbix Biosystems Inc. and as advisor to several Canadian pharmaceutical and medical device companies.

The Honourable James S. Peterson, P.C.

The Honourable James S. Peterson, P.C., served in Parliament for 23 years and, among other positions, was Minister of International Trade, Chair of the Finance Committee and Secretary of State (International Financial Institutions). He is Counsel to Fasken Martineau DuMoulin and Lead Negotiator for Ontario in reducing barriers to trade, investment and labour mobility with Quebec.

Mr. Emanuel Vorona

Mr. Emanuel Vorona is a graduate of York University in Economics. Mr. Vorona is a seasoned businessman with over 25 years of work experience in international markets in the field of natural resources and commodity trading. Currently he is partner and Director of Safia Group, involved in equity investments, mergers and acquisitions worldwide.

Hospital filtration system traps gas

California passes cap and trade bill

In a preview of national regulation to come, California passes legislation intended to regulate the emission of greenhouse gases. Healthcare facilities may soon face additional costs associated with the venting of anesthetics. (www.scpr.org)
...